Wednesday, October 18, 2017 10:15 PM ET
AEVI Genomic Medicine (GNMX) sees Significant Insider Buying Extending the Trend of Last 90 Days
There were noteworthy insider purchases of AEVI Genomic Medicine shares today, as revealed in filings with the SEC as eight insiders listed below, acquired 793,651 shares in the company having a net market value of approximately $1,000,000. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 30,831 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 824,482 shares and have averaged 91,609 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at AEVI Genomic Medicine is higher than its 183-company peer group average. The Biotechnology & Medical Research peer group saw 220 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by AEVI Genomic Medicine insiders is lower than its peers. Within the peer group there were 8,559,925 shares purchased and 51,286,361 shares sold with company insiders selling 194,211 shares on average over this time period.
The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Michael F Cola, Director and Officer, bought 119,047 shares
* Wilbur H Gantz, Director, bought 39,683 shares
* Eugene A Bauer, Director, bought 19,841 shares
* Dr Sol J Barer, Director, bought 421,032 shares
* Alastair J Clemow, Director, bought 19,841 shares
* Joseph J Grano Jr, Director, bought 39,683 shares
* Barbara Gayle Duncan, Director, bought 59,524 shares
* Dr Garry Arthur Neil, Officer, bought 75,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.